meta_pixel
Tapesearch Logo
Log in
HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

017 - Overactive bladder

HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

Sean P. Kane, PharmD, BCPS

Health & Fitness, Medications, Rosalindfranklin, Rfums, Pharmacy, Pharmd, Pharmacist, Medicine, Drugs

5644 Ratings

🗓️ 18 November 2014

⏱️ 23 minutes

🧾️ Download transcript

Summary

In this episode, we discuss the management of overactive bladder, including: oxybutynin (Ditropan, Oxytrol), tolterodine (Detrol), trospium (Sanctura), solifenacin (VESIcare), darifenacin (Enablex), fesoterodine (Toviaz), mirabegron (Myrbetriq), and onabotulinumtoxinA (Botox).

Transcript

Click on a timestamp to play from that location

0:00.0

Welcome to Helix Talk, a podcast presented by the Rosalm Franklin University College of Pharmacy.

0:11.6

This podcast is produced by pharmacy faculty to supplement study material and provide relevant drug and professional topics.

0:19.2

We're hoping that our real-life clinical pearls and discussions will help you stay up to date

0:24.5

and improve your pharmacy knowledge.

0:27.5

This is an educational production copyright Rosalind Franklin University of Medicine and Science.

0:32.7

This podcast contains general information for educational purposes only. This is not professional advice and should

0:40.2

not be used in lieu of obtaining advice from a qualified health care provider. And now, on to the show.

0:51.1

Welcome to episode 17 of Helix Talk. I'm your co-host Dr. Kane.

0:55.1

I'm Dr. Schumann.

0:56.1

And I'm Dr. Patel.

0:57.5

And today we're talking about overactive bladder or OAB.

1:00.9

So what exactly is overactive bladder?

1:03.2

Well, overactive bladder consists of four different types of cardinal symptoms or components.

1:09.4

It could be manifest in terms of urgency, increased frequency

1:13.8

of urination, increased frequency at nighttime, which we call nocturia, or urgency incontinence,

1:21.7

meaning by the time patient is going to the bathroom, there would be a leakage or an accident.

1:26.6

And this is something that, you know, not a lot of people always talk about at the open.

1:31.3

It's one of those kind of taboo topics, but it's fairly well represented in the population.

1:36.3

There's a prevalence at any point in time, you know, 7 to 27% in men, and then a little

1:42.3

bit higher, 9 to 43% in women. And again, there's a lot of

1:45.4

variance in studies because this is something that's not a lot of people are going to admit

1:49.6

or self-report. And even on top of that, you know, symptoms can get better within, let's say,

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Sean P. Kane, PharmD, BCPS, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Sean P. Kane, PharmD, BCPS and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.